BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5055291)

  • 1. Study on stability of drugs in lyophilic suppository bases. 3. Isolation of cyclovegantine, ethionamide and euphyllin degradation products from suppositories.
    Cieszyński T
    Acta Pol Pharm; 1972; 29(1):75-83. PubMed ID: 5055291
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the stability of drugs in lyophilic suppository media. II. Evaluation of decay of cyclovegantine, ethionamide and euphylline in suppositories].
    Cieszyński T
    Acta Pol Pharm; 1971; 28(4):375-84. PubMed ID: 5145789
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stability of drugs in lyophilic suppository bases. V. Identification of products of ethionamide decay isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(5):651-6. PubMed ID: 4447018
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on stability of drugs in lyophilized suppository bases. 1. Separation and detection of products of decomposition of cyclovegantine, ethionamide and euphylline by means of thin-layer chromatography].
    Cieszyński T
    Acta Pol Pharm; 1971; 28(1):59-69. PubMed ID: 5577813
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stability of drugs in lyophilic suppository bases. IV. Identification of decomposition products of cyclovegantine isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(1):99-107. PubMed ID: 4151652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug stability in lyophilic suppository media].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(2):257-8. PubMed ID: 4840677
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug stability in lyophilic suppository bases. VI. Identification of euphylline decay products isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1975; 32(3):371-7. PubMed ID: 1155194
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kinetics of drug degradation. VI. Kinetics of degradation of phenylbutazone (FB) in suppository bases].
    Pawelczyk E; Zajac M
    Acta Pol Pharm; 1970; 27(2):113-7. PubMed ID: 5422244
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability study of aminophylline suppositories. Part I: Decomposition products and specific assay method for ethylenediamine.
    van Dop C; Overvliet GM; Smits HM
    Pharm Acta Helv; 1981; 56(9-10):281-4. PubMed ID: 7291212
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of aminophylline suppositories prepared in a hospital pharmacy.
    Fujii T; Kubota A; Togawa K; Mizushima N
    Tokai J Exp Clin Med; 1982 May; 7(3):371-83. PubMed ID: 7123575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Choice of bases for suppositories with antibiotics. I. Stability of antibiotics in suppository bases].
    Zaremba A; Krówczyński L
    Acta Pol Pharm; 1974; 31(6):769-73. PubMed ID: 4447038
    [No Abstract]   [Full Text] [Related]  

  • 12. Decomposition of aminophylline in suppository formulations.
    Brower JF; Juenge EC; Page DP; Dow ML
    J Pharm Sci; 1980 Aug; 69(8):942-5. PubMed ID: 7400941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physical stability of suppository bases at different temperatures].
    Leszczyńska-Bakal H
    Acta Pol Pharm; 1971; 28(5):531-5. PubMed ID: 5145101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rheological study of suppository bases with special reference to their consistency].
    Regdon G; Mezey G; Regdon G
    Acta Pharm Hung; 1973 Mar; 43(2):57-66. PubMed ID: 4697143
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biopharmaceutical evaluation of aminophylline suppositories. II. Biological availability of aminophylline (theophylline) from suppositories with normal and prolonged time of total deformation].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(1):105-10. PubMed ID: 6496133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(1):99-104. PubMed ID: 6496143
    [No Abstract]   [Full Text] [Related]  

  • 17. Preformulation experiences and in vitro model studies with spironolactone-containing suppositories.
    Regdon G; Deák D; Regdon G; Muskó Z; Erös I
    Pharmazie; 2001 Jan; 56(1):70-3. PubMed ID: 11213791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the polymorphic transition of semisynthetic triglycerides of fatty acid suppository bases].
    Xie XH; Gu XC; Liu FY
    Yao Xue Xue Bao; 1988 May; 23(5):388-93. PubMed ID: 3213521
    [No Abstract]   [Full Text] [Related]  

  • 19. Preformulation studies on suppositories by thermal methods.
    Giordano F; La Manna A; Bettinetti GP; Zamparutti M
    Boll Chim Farm; 1990 Apr; 129(4):160-5. PubMed ID: 2245004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed proton NMR and solid-liquid fat ratio determinations in suppository vehicles and aminophylline suppositories.
    De Blaey CJ; Varkevisser FA; Kalk A
    Pharm Weekbl Sci; 1984 Oct; 6(5):203-8. PubMed ID: 6504688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.